Literature DB >> 1703388

Giant axonal neuropathy (GAN): an immunohistochemical and ultrastructural study report of a Latin American case.

A L Taratuto1, G Sevlever, M Saccoliti, L Caceres, M Schultz.   

Abstract

Giant axonal neuropathy (GAN), a progressive childhood disorder of intermediate filaments (IF), is characterized by a peripheral neuropathy and central nervous system involvement. Twenty-eight cases have been reported while several pathogenic hypotheses have been proposed. Sural nerve biopsy of a 10-year-old Argentinian girl showed a reduced number of myelinated fibers as well as several enlarged axons up to 30 microns in diameter, thinly myelinated or devoid of myelin sheath, displaying accumulation of neurofilaments (NF), but few microtubules (MT) beneath the axolemmal membrane. There was IF accumulation in Schwann and perineural cells as well as in melanocytes, fibroblasts, pericytes, endothelial and epithelial cells in both nerve and skin biopsy. Our findings strongly support GAN as a generalized IF disorder with MT segregation from NF in giant axons. Abnormal NF phosphorylation is suggested by heavy immunostaining of enlarged axons by a monoclonal antibody to NF phosphorylated determinants (SMI 31-Sternberger's) and lack of reaction with a monoclonal antibody with different phosphoepitopes affinity (SMI 34-Sternberger's).

Entities:  

Mesh:

Year:  1990        PMID: 1703388     DOI: 10.1007/bf00307639

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  37 in total

1.  Giant axonal neuropathy: a childhood disorder of microfilaments.

Authors:  T Koch; P Schultz; R Williams; P Lampert
Journal:  Ann Neurol       Date:  1977-05       Impact factor: 10.422

2.  Infantile chronic peripheral neuropathy with giant axons. Report of a case.

Authors:  H Jedrzejowska; H Drac
Journal:  Acta Neuropathol       Date:  1977-03-31       Impact factor: 17.088

Review 3.  Neurofilament protein phosphorylation--where, when and why.

Authors:  A Matus
Journal:  Trends Neurosci       Date:  1988-07       Impact factor: 13.837

4.  Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study.

Authors:  P N Leigh; A Dodson; M Swash; J P Brion; B H Anderton
Journal:  Brain       Date:  1989-04       Impact factor: 13.501

5.  Giant axonal neuropathy: normal protein composition of neurofilaments.

Authors:  V Ionasescu; C Searby; P Rubenstein; A Sandra; P Cancilla; J Robillard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

6.  Giant axonal neuropathy. A clinically and morphologically distinct neurological disease.

Authors:  S Carpenter; G Karpati; F Andermann; R Gold
Journal:  Arch Neurol       Date:  1974-11

7.  Giant axonal neuropathy. Endocrinological and histological studies.

Authors:  A Fois; P Balestri; M A Farnetani; R Berardi; R Mattei; E Laurenzi; C Alessandrini; R Gerli; A Ribuffo; S Calvieri
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

8.  Giant axonal neuropathy. Report of a case with normal hair.

Authors:  E Boltshauser; A Bischoff; W Isler
Journal:  J Neurol Sci       Date:  1977-03       Impact factor: 3.181

Review 9.  Childhood giant axonal neuropathy. Case report and review of the literature.

Authors:  R Tandan; B W Little; E S Emery; P S Good; W W Pendlebury; W G Bradley
Journal:  J Neurol Sci       Date:  1987-12       Impact factor: 3.181

10.  A simple method for removing the resin from epoxy-embedded tissue.

Authors:  H D MAYOR; J C HAMPTON; B ROSARIO
Journal:  J Biophys Biochem Cytol       Date:  1961-04
View more
  2 in total

1.  Giant axonal neuropathy: report on a case with focal fiber loss.

Authors:  M Sabatelli; E Bertini; S Servidei; E Fernandez; S Magi; P Tonali
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  A Stochastic Multiscale Model That Explains the Segregation of Axonal Microtubules and Neurofilaments in Neurological Diseases.

Authors:  Chuan Xue; Blerta Shtylla; Anthony Brown
Journal:  PLoS Comput Biol       Date:  2015-08-18       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.